Oscar Health, Inc.
OSCR · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,986 | $2,864 | $3,046 | $2,393 |
| % Growth | 4.3% | -6% | 27.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2,986 | $2,864 | $3,046 | $2,393 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $534 | $483 | $467 |
| SG&A Expenses | $522 | $534 | $483 | $467 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,594 | $2,551 | $2,275 | $2,080 |
| Operating Expenses | $3,115 | $3,086 | $2,758 | $2,547 |
| Operating Income | -$129 | -$234 | $288 | -$154 |
| % Margin | -4.3% | -8.2% | 9.5% | -6.4% |
| Other Income/Exp. Net | -$10 | $0 | $0 | $0 |
| Pre-Tax Income | -$139 | -$234 | $288 | -$154 |
| Tax Expense | -$2 | -$5 | $13 | -$0 |
| Net Income | -$137 | -$228 | $275 | -$154 |
| % Margin | -4.6% | -8% | 9% | -6.4% |
| EPS | -0.53 | -0.89 | 1.1 | -0.62 |
| % Growth | 40.4% | -180.9% | 277.4% | – |
| EPS Diluted | -0.53 | -0.89 | 0.92 | -0.62 |
| Weighted Avg Shares Out | 259 | 253 | 251 | 240 |
| Weighted Avg Shares Out Dil | 259 | 270 | 306 | 266 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7 | $6 | $6 | $6 |
| Depreciation & Amortization | $7 | $7 | $7 | $9 |
| EBITDA | -$125 | -$221 | $301 | -$138 |
| % Margin | -4.2% | -7.7% | 9.9% | -5.8% |